Sfoglia per AUTORE
DIMIER N
Collezione AOU Città della Salute di Torino
Items : 2
Minimal Residual Disease-Based End Point for Accelerated Assessment of Clinical Trials in Multiple Myeloma: A Pooled Analysis of Individual Patient Data From Multiple Randomized Trials. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2025 Feb 12:JCO2402020. doi: 10.1200/JCO-24-02020.
2025
AOU Città della Salute di Torino
AOU Città della Salute di Torino
Shi Q; Paiva B; Pederson LD; Dimier N; Talpes E; Prior TJ; Orfao A; Moreau P; Sonneveld P; Kumar SK; Dixon JG; Patel R; Bartlett BJ; Schecter J; McCarthy P; Hose D; Seckinger A; Mattia D; Goldschmidt H; Oliva S; Owen RG; Anderson KC; San-Miguel J; Durie BGM; Munshi N;
A phase Ib study to assess the efficacy and safety of vismodegib in combination with ruxolitinib in patients with intermediate- or high-risk myelofibrosis. in Journal of hematology & oncology / J Hematol Oncol. 2018 Sep 24;11(1):122. doi: 10.1186/s13045-018-0661-x.
2018
AOU Città della Salute di Torino
AOU Città della Salute di Torino
Couban S; Benevolo G; Donnellan W; Cultrera J; Koschmieder S; Verstovsek S; Hooper G; Hertig C; Tandon M; Dimier N; Malhi V; Passamonti F; Couban S; Benevolo G; Donnellan W; Cultrera J; Koschmieder S; Verstovsek S; Hooper G; Hertig C; Tandon M; Dimier N; Malhi V; Passamonti F;